BIO Letter to White House on Need for Animal Biotech Reform in Wake of COVID-19
April 7, 2020
As part of the Administration’s comprehensive response to the unprecedented health and economic impacts from the COVID-19 pandemic, the Biotechnology Innovation Organization (BIO) respectfully requests that the U.S. government immediately reform its approach to oversight of animals with intentional genomic alterations. We are calling on the White House to direct the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) to develop and execute a memorandum of understanding (MOU) clarifying regulatory responsibilities over these animals within 30 days.
Download Full Comments Below
BIO Greenwood Letter to President Trump on Animal Biotech
BIO provides detailed comments in advance of the July 31, 2023 NIH Workshop, “Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer.
As organizations representing America’s highly innovative and competitive food and agricultural value chain, we write to express our thanks for USTR’s announcement that it will begin technical consultations with Mexico concerning its action to ban…
BIO submitted a statement for the record to the Senate Committee on Agriculture, Nutrition and Forestry hearing titled "Farm Bill 2023: Rural Development and Energy Programs." BIO called for a "farm bill centered on innovation" to incentivize…
As part of the Administration’s comprehensive response to the unprecedented health and economic impacts from the COVID-19 pandemic, the Biotechnology Innovation Organization (BIO) respectfully requests that the U.S. government immediately reform its approach to oversight of animals with intentional genomic alterations. We are calling on the White House to direct the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) to develop and execute a memorandum of understanding (MOU) clarifying regulatory responsibilities over these animals within 30 days.